New blood-based metabolomics test predicts asthma attacks up to five years ahead, helping identify high-risk patients before ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase in mortality and morbidity in recent years, affecting all age groups ...

Early Phase I data showed inhaled londamocitinib reduced airway inflammation in mild asthma with good tolerability. Learn ...

China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma: London, UK Saturday, January 24, 2026, 09:00 Hrs [IST] GSK plc announced that China’s Nat ...

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

Respiratory specialists Dr Anna Haley and Dr Nita Sehgal discuss the key principles in management of asthma during pregnancy ...

Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets ...

The high exposure to pollutants has led to a decline in lung immunity. Here is how drinking an immunity shot with ajwain ...

Researchers at DTU have patented a new invention that uses naturally produced substances from bifidobacteria in the gut to help lower the risk of allergies and asthma. Allergies and asthma are ...

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

Researchers developed a blood test that predicts asthma attack risk up to 5 years ahead with 90% accuracy, enabling earlier ...

When COVID hit, health care systems around the world were turned upside down. Hospitals cleared beds, routine appointments ...